Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pedro G. Hernandez-Sanchez"'
Autor:
Jose S. Altamirano-Flores, Sandra E. Guerra-Palomares, Pedro G. Hernandez-Sanchez, Jose L. Ramirez-Garcialuna, J. Rafael Arguello-Astorga, Daniel E. Noyola, Juan C. Cuevas-Tello, Christian A. Garcia-Sepulveda
Publikováno v:
IEEE Access, Vol 8, Pp 87214-87227 (2020)
The Human Immunodeficiency Virus (HIV) Viral Infectivity Factor (Vif) is a 192-amino acid accessory protein essential to viral replication which counteracts host APOBEC3 proteins. APOBEC3 proteins interfere with the replication of HIV, hepatitis C vi
Externí odkaz:
https://doaj.org/article/390aa82abb7240aa932434922059ac78
Autor:
Mary Carrington, Danillo G. Augusto, Christian A. García-Sepúlveda, Gaurav Sharma, Niamh Spence, Xiaojiang Gao, Veron Ramsuran, Gurvinder Kaur, Colm O'hUigin, Narinder K. Mehra, Pedro G. Hernandez-Sanchez
Publikováno v:
The Journal of Immunology. 198:2320-2329
Polymorphisms located within the MHC have been linked to many disease outcomes by mechanisms not yet fully understood in most cases. Variants located within untranslated regions of HLA genes are involved in allele-specific expression and may therefor
Autor:
J. Rafael Arguello, Daniel E. Noyola, Christian A. García-Sepúlveda, Sandra Elizabeth Guerra-Palomares, Pedro G. Hernandez-Sanchez
Publikováno v:
AIDS Research and Human Retroviruses. 36:457-458
Autor:
J. Rafael Arguello, Pedro G. Hernandez-Sanchez, Sandra Elizabeth Guerra-Palomares, Daniel E. Noyola, Christian A. García-Sepúlveda
Publikováno v:
AIDS research and human retroviruses. 36(2)
Protease is one of three enzymes encoded within HIV's pol gene, responsible for the cleavage of viral Gag-Pol polypeptide into mature viral proteins and a target of current anti-retroviral therapy. Protease diversity analysis in Latin America has bee
Autor:
Jesus Rafael Arguello, Pedro G. Hernandez-Sanchez, Jose Luis Ramirez-GarciaLuna, Christian A. García-Sepúlveda, Sandra Elizabeth Guerra-Palomares, Daniel E. Noyola
Publikováno v:
AIDS research and human retroviruses. 34(6)
This study set out to determine the frequency of antiretroviral drug resistance mutations in treatment-naive subjects of the north central Mexican state of San Luis Potosi. Mexican studies of antiretroviral drug resistance mutations have focused main